DE69822009D1 - Indometacin Calciumsalz Pentahydrat und deren Herstellung - Google Patents

Indometacin Calciumsalz Pentahydrat und deren Herstellung

Info

Publication number
DE69822009D1
DE69822009D1 DE69822009T DE69822009T DE69822009D1 DE 69822009 D1 DE69822009 D1 DE 69822009D1 DE 69822009 T DE69822009 T DE 69822009T DE 69822009 T DE69822009 T DE 69822009T DE 69822009 D1 DE69822009 D1 DE 69822009D1
Authority
DE
Germany
Prior art keywords
calcium salt
indomethacin
preparation
salt pentahydrate
pentahydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69822009T
Other languages
English (en)
Other versions
DE69822009T2 (de
Inventor
Abderrahim Bennis
Jean-Jacques Serrano
Farid Bennis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROMINDUS ACTIONS PROMOTIONNEL
Original Assignee
PROMINDUS ACTIONS PROMOTIONNEL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PROMINDUS ACTIONS PROMOTIONNEL filed Critical PROMINDUS ACTIONS PROMOTIONNEL
Publication of DE69822009D1 publication Critical patent/DE69822009D1/de
Application granted granted Critical
Publication of DE69822009T2 publication Critical patent/DE69822009T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
DE69822009T 1997-01-29 1998-01-28 Indometacin Calciumsalz Pentahydrat und deren Herstellung Expired - Lifetime DE69822009T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9700925A FR2758819B1 (fr) 1997-01-29 1997-01-29 Indometacine calcique et sa preparation

Publications (2)

Publication Number Publication Date
DE69822009D1 true DE69822009D1 (de) 2004-04-08
DE69822009T2 DE69822009T2 (de) 2004-10-21

Family

ID=9503072

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69822009T Expired - Lifetime DE69822009T2 (de) 1997-01-29 1998-01-28 Indometacin Calciumsalz Pentahydrat und deren Herstellung

Country Status (7)

Country Link
EP (1) EP0856511B1 (de)
AT (1) ATE260895T1 (de)
DE (1) DE69822009T2 (de)
ES (1) ES2217512T3 (de)
FR (1) FR2758819B1 (de)
MA (1) MA24450A1 (de)
PT (1) PT856511E (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2820636B1 (fr) * 2001-02-09 2007-10-05 Laprophan Laboratoires De Prod Utilisation de l'indometacine calcique pour traiter les pathologies a mediation de la cyclo-oxygenase 2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK244179A (da) * 1978-06-13 1979-12-14 Merck & Co Inc Fremgangsmaade til fremstilling af krystallinsk natrium og kaliumindomethacin og trihydrater deraf
JPH06104624B2 (ja) * 1986-05-07 1994-12-21 太郎 小木曽 経皮吸収剤
ES2098264T3 (es) * 1989-05-22 1997-05-01 Biochemical Veterinary Res Sales metalicas divalentes de indometacina.

Also Published As

Publication number Publication date
FR2758819B1 (fr) 2000-01-21
EP0856511A1 (de) 1998-08-05
MA24450A1 (fr) 1998-10-01
FR2758819A1 (fr) 1998-07-31
ES2217512T3 (es) 2004-11-01
ATE260895T1 (de) 2004-03-15
PT856511E (pt) 2004-07-30
EP0856511B1 (de) 2004-03-03
DE69822009T2 (de) 2004-10-21

Similar Documents

Publication Publication Date Title
DE69415316D1 (de) Sulfonamide und derivate zur modulierung der endothelin aktivitat
SE9604786D0 (sv) New compounds
DE69738245D1 (de) 1,2-Diphenylpyrrol-Derivate, ihre Herstellung und therapeutische Verwendung
GB9801690D0 (en) Therapeutic agents
ATE174872T1 (de) Carbonierte hydroxyapatit-zusammensetzungen und ihre verwendungen
FI963169A0 (fi) Enkefalinaasin ja ACE:n inhibittoreina käyttökelpoisia uusia merkaptoasetyyliamido-1,3,4,5-tetrahydrobents/c/-atsepin-3-onidisulfidijohdannaisia
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
ATE263771T1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
FI861506A (fi) Foerfarande foer framstaellning av 1,2-ditiolan-3-pentansyra (tioktsyra).
ATE231859T1 (de) Tetrahydrothiopyran-phenyloxazolidinon-s-oxide
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
NO995963D0 (no) Karboksamider anvendelige som 5-HTIF-agonister
ES2179254T3 (es) 1-poliarilpirazoles plaguicidas.
ATE80392T1 (de) Oxadiazolylacetonitrile, ihre herstellung und anwendung.
TW228520B (de)
DK1073447T3 (da) N1-modificerede glycopeptider
DE69822009T2 (de) Indometacin Calciumsalz Pentahydrat und deren Herstellung
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
FI930092A (fi) Indanopyrrolidinkarbamater
ATE192141T1 (de) Aromatische hydroxamsäure-verbindungen, ihre herstellung und verwendung
NO304314B1 (no) Cykloheksanderivater og anvendelse av forbindelsene for fremstilling av legemidler
DK0520372T3 (da) Inositol-phosphat-analoger som calciumantagonistiske stoffer
ATE265854T1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
DE69511449D1 (de) Octahydro-2-Naphthalincarbonsäure-Derivate, ihre Herstellung und Verwendung
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen